ArticleScientific reports2026
Developing antibacterial Zn-Cu-Mg alloys with high strength and osteogenic stimulation for osteomyelitis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Biodegradable metals are promising candidates for osteomyelitis management because they can provide mechanical support, enable tunable degradation, display inherent antibacterial effects, and stimulate osteogenesis. Here, Zn alloys incorporating Cu and Mg were designed as multifunctional implant materials to concurrently suppress infection and promote bone regeneration. Equal channel angular pressing (ECAP) was used to refine grains to the submicron scale and substantially fragment secondary phases. Mechanical testing showed that Zn-1Cu-1Mg alloy achieved the highest hardness and tensile strength among the investigated alloys, which is attributed to the combined contributions of grain refinement and second-phase strengthening. Electrochemical and immersion evaluations further indicated that the addition of Cu improved corrosion resistance of Zn-1Mg alloy. The reduced corrosion rate is associated with the formation of compact corrosion layers enriched in Zn, O, C, Ca, P, and Cl. In vitro assays using BMSCs demonstrated high cell viability, meanwhile, osteogenic assessments revealed enhanced ALP activity, increased mineralized nodule formation, and upregulated osteogenic gene expression. All Zn alloys also showed pronounced antibacterial activity against S. aureus and E. coli. Collectively, these results suggest that Zn-1Cu-1Mg alloys offer a multifunctional biodegradable option for osteomyelitis through the integration of infection control and bone regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.